CRP/Albumin Has a Promising Prospect as a New Biomarker for the Diagnosis of Periprosthetic Joint Infection

Abstract

Purpose

In the present study, we aimed to identify more effective biomarkers for the diagnosis of periprosthetic joint infection (PJI) by comparing the diagnostic ability of C-reactive protein (CRP)/albumin, systemic immune-inflammation index (SII), and existing biomarkers.

Methods

In this single-center retrospective analysis, 216 patients who underwent revision knee or hip arthroplasty from June 2013 to June 2021 and met the inclusion and exclusion criteria were analyzed, including 80 patients in the PJI group and 136 patients in the non-PJI group. The following information was collected for analysis, including CRP, fibrinogen, erythrocyte sedimentation rate (ESR), D-dimer, platelet count (PC), neutrophil count (N), lymphocyte count (Lym), and albumin count on the second day of admission. The receiver operating characteristic (ROC) curve was used to compare the diagnostic ability of various biomarkers, and further subgroup analysis was carried out in the PJI group.

Results

Compared with the non-PJI group, CRP, fibrinogen, D-dimer, ESR, CRP/albumin, and SII in the PJI group were significantly increased (P < 0.001), and their area under the curve (AUC) was 0.937, 0.878, 0.777, 0.914, 0.941, and 0.765, respectively. In the three subgroup analyses, there was no significant difference in appeal biomarker (P > 0.05) based on PJI culture results, infection time, and infection site.

Conclusion

CRP/albumin had a promising prospect as a new biomarker for the diagnosis of PJI, while it had insufficient predictive ability in the PJI subgroup analysis. However, SII had insufficient ability to diagnose PJI. Therefore, SII was not suitable to be used as a diagnostic biomarker.

Keywords:

• periprosthetic joint infection
• CRP/albumin
• systemic immune-inflammation index
• biomarker

Introduction

As one of the serious complications after total joint infection (TJA), periprosthetic joint infection (PJI) has a global incidence of about 5–20%,^1,2 and aseptic loosening also greatly contributes to the failure of TJA.³ In 2011, the American Musculoskeletal Infection Society (MSIS) has proposed that the sinus communicating with the prosthesis or the affected joint with positive culture twice and the same bacteria can be used as the main standard of PJI, and the elevation of C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) is the secondary standard of diagnosis.⁴ In 2013, the International Consensus Meeting (ICM) has added new biomarkers, including leukocyte esterase, based on MSIS and set the diagnostic threshold of acute and chronic infections.⁵ In 2018, Parvizi et al have summarized the original consensus and guidelines and formulated a new set of score-based diagnostic criteria for PJI, which has high sensitivity and specificity for the diagnosis of PJI.²³

Routine plasma biomarkers, such as CRP and ESR, are widely used in clinical screening for infection because of their simple operation and economic effectiveness. However, both indicators will increase after TJA. Therefore, their diagnostic efficacy in the acute stage of infection is limited. Fibrinogen is one of the coagulation biomarkers for the traditional diagnosis of venous thrombosis and other diseases. Besides, fibrinogen is also an acute-phase player in the pathogenesis of infection. Xu et al⁶ have found that compared with other serum biomarkers, the level of plasma fibrinogen shows a better diagnostic effect before the revision of joint arthroplasty. Some recent investigations have shown that the CRP/albumin ratio is independently related to Gram-negative neonatal sepsis, and such a ratio can be used to predict Gram-negative bacteremia.⁷ Meanwhile, the CRP/albumin also exhibits good predictive value in acute pancreatitis and surgical site infection (SSI) after major abdominal surgery.^8,9 The elevation of systemic immune-inflammation index (SII) value is mainly attributed to the increased neutrophil and platelet levels and the reduced lymphocyte levels, suggesting that the inflammatory response of patients is elevated, and the immune response is deteriorated.¹⁰ The diagnostic ability of the latter two indicators in infection has been confirmed, while there is no report on the performance in the diagnosis of PJI.

In the present study, we aimed to (1) compare whether CRP/albumin and SII were better than commonly used biomarkers in the diagnosis of PJI; and (2) explore the predictive ability of appeal biomarkers in culture-positive/negative PJI, acute/chronic PJI, knee/hip PJI, and cocci/bacilli PJI.

Materials and Methods

This study was approved by the ethical committee of our institution, and experimental procedures were conducted following the declaration of Helsinki. All patients provided written informed consent before operation. A total of 271 patients who underwent revision of knee or hip arthroplasty in our institution from June 2013 to June 2021 were retrospectively analyzed in the present study. Patients diagnosed with a periprosthetic fracture or prosthesis dislocation (n = 28) were excluded. To exclude factors that might affect the results, patients with autoimmune diseases (n = 5), malignant tumors (n = 3), and hematological diseases, those using anticoagulant drugs for various reasons (n = 16), and individuals with incomplete information (n = 3) were excluded from the study cohort. Finally, 216 patients were included in the research regimen. There were 80 patients in the PJI group and 136 patients in the non-PJI group, including patients with aseptic loosening, joint instability, and unexplained pain. All PJI patients met the diagnostic criteria of PJI introduced by the International Consensus Meeting (ICM) in 2018.²³

Data Extraction

The basic information of all patients was acquired from the electronic medical record system of the institution, including age, location, time, symptoms, and complications. The patients were forbidden to eat and drink in the early morning of the day after hospitalization, and the venous blood samples were collected the next morning and sent to the laboratory within 1 h. The levels of CRP, ESR, fibrinogen, D-dimer, platelet count (PC), neutrophils (N), lymphocytes (Lym), and albumin were analyzed. The SII was determined using the above-mentioned indicators with an equation as follows: SII = platelet count * neutrophil count/lymphocyte count.

Biomarker testing methods: CRP: nephelometry immunoassay (0~5.00 mg/L); ESR: Westergren method (male 0~15 mm/h, female 0~30 mm/h); fibrinogen: Clauss method (2.00~4.00 g/L); D-dimer: turbidimetric immunoassay (0~500.00 ng/mL); PC, N, Lym: flow cytometry method; albumin, colorimetry (Bromocresol Green, BCG).

Apart from biomarker testing, specimens of joint fluid/pus and periprosthetic tissues obtained from patients with confirmed or suspected PJI were cultured under aerobic and anaerobic conditions, and histopathologic examination of bones or periprosthetic tissues were carried out.

Statistical Analyses

SPSS version 26.0 (IBM Inc., Armonk, NY, USA) was used for all statistical analyses. Normally distributed variables were analyzed using a t-test, and the Mann–Whitney U-test was adopted for the comparison between the two groups. All data were presented as mean ± standard deviation. The count data between groups were compared with Chi-square, and descriptive statistics were presented as frequency or percentage. P less than 0.05 was considered statistically significant. The area under the curve (AUC), 95% confidence interval (CI), and sensitivity and specificity of different markers were determined using the working subject curve. The best cut-off value, positive predictive value (PPV), and negative predictive value (NPV) of markers were determined according to the Youden index. An AUC value of 0.900–1.000 was defined as excellent, 0.800–0.899 was good, 0.700–0.799 was fair, 0.600–0.699 was poor, and 0.500–0.599 indicated no diagnostic ability.¹¹

Results

Demographic Characteristics of Patients

No significant difference in terms of gender and age was detected among 216 included subjects (P > 0.05). The body mass index (BMI) of the PJI group was remarkably greater compared with the non-PJI group (P < 0.05), while more revision hip arthroplasty was found in the non-PJI group compared with the PJI group (P < 0.001) (Table 1).

Table 1 Demographic Characteristics of All Patients

	PJI^a(n=80)	Non-PJI(n=136)	P value
Gender			0.942
Male (%)	41(52.5)	69(50.7)
Female (%)	39(47.5)	67(49.3)
Age(y)	64.61±10.02	65.12±9.75	0.673
BMI^b(kg/m2)	25.82±4.11	24.70±3.49	0.017
Joint			<0.001
Knee (%)	42(52.5)	27(19.9)
Hip (%)	38(47.5)	109(80.1)

Abbreviations: ^aPJI, periprosthetic joint infection; ^bBMI, body mass index.

Diagnostic Value of Different Biomarkers in PJI

We compared the diagnostic abilities of several preoperative biomarkers (CRP, fibrinogen, D-dimer, and ESR), including their counts or ratios (CRP/albumin and SII) between the two groups. The biomarker count and ratio in the PJI group were remarkably greater compared with the non-PJI group (P < 0.001) (Table 2). ROC (Figure 1) showed that the AUC (95% CI) of the six biomarkers was 0.937 (0.903 ~ 0.972), 0.878 (0.831~0.925), 0.777 (0.712~0.842), 0.914 (0.877 ~ 0.952), 0.941 (0.907 ~ 0.975), and 0.765 (0.697 ~ 0.833), respectively. CRP/albumin, one of the main research objectives of this study, performed best, two traditional biomarkers (CRP and ESR) performed excellently, and two fibrinolytic markers (fibrinogen and D-dimer) performed well. However, the diagnostic value of another research index SII was fair, which performed worst among all indicators (Table 3).

Table 2 Comparison of Different Biomarkers Between PJI and Non-PJI

	PJI^a(n=80)	Non-PJI(n=136)	P value
CRP^b(mg/L)	40.15±47.33	3.57±4.96	<0.001
Fibrinogen(g/L)	4.72±1.32	2.99±0.80	<0.001
D-dimer(ng/mL)	1121.88±917.09	488.05±266.92	<0.001
ESR^c(mm/h)	45.78±25.50	12.88±10.52	<0.001
CRP/albumin	1.19±1.49	0.09±0.15	<0.001
SII^d	967.26±905.48	445.69±342.21	<0.001

Abbreviations: ^aPJI, periprosthetic joint infection; ^bCRP,C-reactive protein; ^cESR,erythrocyte sedimentation rate; ^dSII,systemic immune-inflammation index.

Table 3 Diagnostic Value of CRP, Fibrinogen, D-Dimer, ESR, CRP/Albumin, and SII for PJI

	AUC	95% CI	Youden Index	Optimal Cutoff Value	Sensitivity	Specificity	PPV^a	NPV^b
CRP^c(mg/L)	0.937	(0.903,0.972)	0.767	8.73	86.3%	90.4%	84.1%	91.8%
Fibrinogen(g/L)	0.878	(0.831,0.925)	0.626	3.68	78.7%	83.8%	77.6%	87.0%
D-dimer(ng/mL)	0.777	(0.712,0.842)	0.407	545	73.8%	66.9%	56.2%	81.1%
ESR^d(mm/h)	0.914	(0.877,0.952)	0.692	26.50	78.8%	90.4%	82.9%	87.9%
CRP/albumin	0.941	(0.907,0.975)	0.787	0.27	83.8%	94.9%	90.4%	90.2%
SII^e	0.765	(0.697,0.833)	0.401	827.63	47.5%	92.6%	79.2%	75.0%

Abbreviations: ^aPPV, positive predictive value; ^bNPV, negative predictive value; ^cCRP,C-reactive protein; ^dESR,erythrocyte sedimentation rate; ^eSII,systemic immune-inflammation index.

Figure 1 The ROC curves of plasma CRP, Fibrinogen, D-dimer, ESR, CRP/albumin and SII. Among the six biomarkers, the AUC of CRP / albumin is the largest and that of SII is the smallest, indicating that CRP / albumin has the best ability to diagnose PJI, while SII is the worst.

Based on the Youden index, we further calculated the optimal cutoff value, sensitivity, specificity, PPV, and NPV of each biomarker (Table 3). The sensitivity of CRP was the highest (86.3%), followed by CRP/albumin (83.8%), while the sensitivity of SII was only 47.5%. In terms of specificity, CRP/albumin and SII performed best, with a specificity of 94.9% and 92.6%, respectively, and the specificity of D-dimer remained low (66.9%). CRP/albumin performed well in both PPV and NPV (90.4% and 90.2%, respectively), while SII performed generally fair (79.2% and 75.0%, respectively) (Table 3).

Predictive Value of Different Biomarkers in Subgroup Analysis

In the present study, a subgroup analysis was carried out according to the culture results, including infection time, infection site, and types of infected bacteria of PJI patients. Among the 80 PJI patients, 54 were culture positive, and 26 were culture negative. No significant difference in biomarkers, except for ESR (45.71 vs 45.92 mm/h), was detected between the two subgroups, the other five biomarkers of culture-positive patients were only relatively greater compared with culture-negative patients (Table 4). The subjects infected within 3 months were defined as acute PJI, and those infected more than 3 months were regarded as chronic PJI.¹¹ The results in the analysis of acute and chronic PJI, knee and hip PJI, cocci, and bacilli PJI subgroups were similar. Although relative differences were detected in different biomarkers among different subgroups, such differences remained non-statistically meaningful (P > 0.05) (Table 4).

Table 4 Comparison of All Biomarkers in Different PJI Subgroups

	Culture Positive PJI (n=54)	Culture Negative PJI (n=26)	P value	Acute PJI^a (n=10)	Chronic PJI (n=70)	P value	Knee PJI (n=42)	Hip PJI (n=38)	P value	Cocci* (n=39)	Bacilli* (n=13)	P value
CRP^b (mg/L)	44.85±51.28	30.40±36.83	0.254	41.96±47.68	39.89±47.62	0.663	33.27±40.48	47.76±53.42	0.203	50.65±57.18	31.71±28.74	0.404
Fibrinogen (g/L)	4.77±1.22	4.64±1.53	0.488	4.86±1.08	4.70±1.36	0.621	4.47±1.23	5.00±1.38	0.122	4.80±1.34	4.79±0.90	0941
D-dimer (ng/mL)	1139.26±842.10	1085.77±1073.48	0.369	1192.00±1251.31	1111.86±870.57	0.379	1230.00±1063.09	1002.37±717.98	0.316	1236.41±858.70	903.85±815.07	0.074
ESR^c (mm/h)	45.71±26.11	45.92±24.71	0.865	46.48±21.85	45.67±26.12	0.760	45.42±25.68	46.17±25.65	0.981	45.80±27.08	47.95±25.20	0.941
CRP/albumin	1.34±1.61	0.89±1.99	0.145	1.24±1.54	1.19±1.50	0.673	0.95±1.21	1.46±1.73	0.244	1.52±1.81	0.93±0.83	0.479
SII^d	1000.44±1038.82	898.35±543.80	0.689	823.94±573.18	987.74±944.70	0.652	831.91±707.06	1116.86±1073.69	0.112	1037.54±1177.84	949.81±573.89	0.392

Note: *The subgroup excluded 1 case of fungal infection and 1 case of cocci/bacilli mixed infection.

Abbreviations: ^aPJI, periprosthetic joint infection; ^bCRP, C-reactive protein; ^cESR, erythrocyte sedimentation rate; ^dSII, systemic immune-inflammation index.

Discussion

We, for the first time, showed that CRP/albumin had a better diagnostic effect on the diagnosis of PJI compared with traditional biomarkers (CRP, ESR, and D-dimer). Although it could not provide better predictive ability in subgroup analysis, this biomarker still had good application prospects. Compared with CRP/albumin, SII had limited value in the diagnosis of PJI and could not be used as a diagnostic biomarker of PJI at present. Our results also showed that the existing biomarkers did not have good predictive value when distinguishing PJI from different culture results, different strains, different infection times, and different infection sites.

PJI is a disastrous result after total joint replacement. However, in the early stage after TJA, CRP, ESR, and other biomarkers are elevated because of the stress response of the body,¹² and the chronic inflammatory response caused by the prosthetic device will also exhibit symptoms similar to PJI,¹³ such as pain and elevated inflammatory indicators. Therefore, how to quickly and accurately distinguish PJI and aseptic loosening has always been an issue in clinical practice. It also has important guiding significance for the following targeted treatment. However, at present, no effective gold standard has not been found. Recent studies have reported the potential of fibrinolytic indicators (including fibrinogen, FDP, and D-dimer),^6,13,14 platelet-related indicators (such as PC, PC/volume),¹⁵ and protein-related biomarkers (such as albumin, globulin, and albumin-globulin ratio) in the diagnosis of PJI.¹¹ Recent non-orthopedic reports have shown that CRP/albumin and SII have good predictive values in SSI, and prognosis of department of general surgery and neonatal sepsis.^7–10

In our study, the specificity of CRP reached 90.4%, which was considered to be related to the exclusion of patients with autoimmune diseases and other complications. However, in some studies, CRP shows low sensitivity, which may be attributed to that the pathogenic bacteria are low-virulence microorganisms, which form a biofilm to protect the pathogen against the host immune system and reduce the host immune response, leading to reduced release of inflammatory markers. The CRP concentration in serum is low.¹⁷ In addition, a study believes that CRP cannot be adopted as the diagnostic standard in low-virulence pathogen infection and chronic PJI.¹⁸ Other similar studies have also reported that it is highly possible to have a false-negative result in the diagnosis of PJI based on serum CRP.¹⁶ Many influencing factors were excluded from this study. Therefore, the results of CRP were better than previous studies. However, the patients’ conditions are complicated in clinical practice, and CRP has certain limitations in predicting infections. The research on albumin in the existing literature mainly focuses on evaluating the nutritional status of the body. Some studies have reported that the albumin content may alter during infection,¹⁹ while Cao et al have shown that no apparent correlation exists between albumin and PJI.¹¹ We considered that it might be related to the long half-life of serum albumin, and its concentration would not change dramatically with the acute inflammatory reaction.

Based on the limitation of CRP and albumin in diagnosing infection alone, scholars have taken CRP/albumin as a new biomarker to study its ability to predict infection in recent years.^7,9 CRP and albumin are biomarkers for routine admission detection, which are economical and convenient. In addition, CRP/albumin, as a ratio, can reduce the error caused by a single factor of CRP or albumin.

Therefore, we, for the first time, introduced this biomarker into the diagnostic approach of PJI and aimed to explore its new value in the field of joint infection. We found that the AUC (0.941) of CRP/albumin was better compared with CRP (0.937), ESR (0.914), and fibrinogen (0.878), and the best cut-off value was 0.27. According to the calculation results of the Youden index, CRP/albumin was as sensitive as CRP, while it had the highest specificity. The above-mentioned data showed that CRP/albumin had a better comprehensive ability compared with traditional biomarkers in the diagnosis of PJI. Given the different treatment schemes for different types of PJI, especially the different types of antibiotics used by cocci and bacilli, this study conducted a subgroup analysis of PJI patients. However, in the subgroup analysis, there was no significant difference among all biomarkers including CRP/albumin of culture-positive and culture-negative PJI groups, acute and chronic PJI groups, knee and hip PJI groups, and cocci and bacilli PJI groups, indicating that the predictive ability of biomarkers was insufficient. Wang et al have also reported that D-dimer and fibrinogen cannot distinguish culture positive and negative PJI.²⁰

SII is first developed as a tool to predict the prognosis of liver cancer based on lymphocytes, neutrophils, and PC. Its principle is mainly realized through the functions of three types of cells and their interactions with tumor cells. PC decrease, neutrophil increase, or lymphocyte decrease suggests that the inflammatory state is elevated, and the immune state is exacerbated.¹⁰ At present, the ratio of neutrophils/lymphocytes (NLR) has been shown to have the ability to diagnose PJI,^21,22 and PC/lymphocytes (PLR) is markedly associated with early PJI.²² Therefore, whether SII constructed by these three kinds of cells has the same diagnostic value has aroused our interest. In the present study, we, for the first time, designed an experiment to verify the ability of SII to diagnose PJI.

However, SII did not achieve the expected effect in this study. Through AUC, we found that the diagnostic ability of SII was general (0.765), and the performance of SII was the worst among the six biomarkers, which was significantly lower compared with other traditional biomarkers, such as CRP and ESR, or our latest marker CRP/albumin. The sensitivity of SII was only 47.5%, and its specificity was 92.6%, indicating that it could only be an exclusion index rather than a diagnostic index for the diagnosis of PJI. Further analysis indicated that SII had no significant difference in all subgroups. In conclusion, SII could not diagnose PJI at present.

There are several limitations in our current work. The single-center retrospective study is inevitably affected by the existing data, and the inherent bias is difficult to avoid. The sample size is small, especially there are only 10 cases of acute PJI. The findings of the subgroup analysis need to be verified using large samples of acute PJI. In our present study, all patients with complications were excluded, resulting in reduced reliability of conclusions. Whether the new biomarker is also applicable to these patients will be verified in the next research.

Conclusions

Collectively, CRP/albumin was a simple and economical biomarker with excellent diagnostic ability. It could be used as a routine prediction tool for the clinical diagnosis of PJI. Moreover, SII had a poor diagnostic ability for PJI, and it was not suitable to be used as a diagnostic biomarker at present.

Data Sharing Statement

All the case details can publish when approval is obtained from the Institutional Review Board (IRB) Affiliated Hospital of Qingdao University.

Ethics Approval and Consent to Participate

This study was approved by the Institutional Review Board (IRB) Affiliated Hospital of Qingdao University. All personal details were erased before analysis to cover patient data confidentiality and comply with the Declaration of Helsinki.

Consent for Publication

All authors agreed on the final version of the manuscript.

Disclosure

The authors declare they have no conflicts of interest.